Global DNA Methylation Market Size Valuation Estimated to Touch USD 3,840.53 Million By 2030, With 14.5% CAGR: Polaris Market Research

[115+ Pages Research Study] According to Polaris Market Research report, the global DNA methylation market size & share expected to generate revenue cap of USD 3,840.53 Million by 2030 and estimated to be valued at USD 1,140.77 Million in 2021, at a compound annual growth rate (CAGR) of 14.5% from 2022 to 2030. The top market company profiles included in report with their sales, revenues and strategies are Abcam, Active Motif, Agilent Technologies, BioRad Laboratories, Diagenode Diagnostics., EpiGentek Group, Exact Sciences Corp., Roche Ltd and Others.

New York, NY, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “DNA Methylation Market Share, Size, Trends, Industry Analysis Report, By Technology (PCR, Microarray, Sequencing), By Application (Gene Therapy, Diagnostics), By Product, By End-use, By Region; Segment Forecast, 2022-30” in its research database.

“According to the latest research study, the global DNA methylation market size & share are expected to generate revenue of USD 3,840.53 Million By 2030 and are estimated to be valued at USD 1,140.77 Million in 2021, at a compound annual growth rate (CAGR) of 14.5% from 2022 to 2030”

What is DNA Methylation? How Big is DNA Methylation Market Size & Share?

  • Overview

DNA methylation is the biological process that forms by the addition of methyl groups into a methyl (CH3) group of DNA molecule. It involves combinations of four nucleotides, including cytosine, guanine, thymine, and adenine. DNA This mechanism has the ability to modify the function of a DNA segment and regulate gene repression without changing the order. DNA is essential for both healthy growth and development, and it performs a critical role in several important processes, such as X-chromosome inactivation, genomic imprinting, repression of transposable elements, aging, and carcinogenesis.

Researchers are investigating the association between DNA methylation and human diseases like lupus, cancer, muscular dystrophy, and various congenital defects. The study could make a significant contribution to the development of therapies and prevention techniques for the conditions that occur due to the abnormal methylation of the X chromosome and gene imprinting during embryonic development. The DNA methylation market size is expected to thrive positively due to the current research & developments for the treatment of rare and undiagnosed diseases.

Request Sample Copy of DNA Methylation Market Research Report @

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Our Sample Report May Includes:

  • 2030 Updated Report Introduction, Overview, and In-depth industry analysis.
  • 115+ Pages Research Report (Inclusion of Updated Research).
  • Provide Chapter-wise guidance on Request.
  • 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of tables & figures.
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.

Key Offerings of This Report

  • Market size and share assessment for regional and country-level segments.
  • Business opportunities, drivers, and success factors.
  • Current trends and the future potential of the market.
  • Market segment analysis by types, applications, and regions.
  • The competitive status of key players within the projection timeline.
  • Value chain analysis with price analysis and DNA methylation market forecast.
  • Region-specific growth and development in the market.

Some of the Top Market Players Covered in this Report:

  • Abcam
  • Active Motif
  • Agilent Technologies
  • BioRad Laboratories
  • Diagenode Diagnostics.
  • EpiGentek Group
  • Exact Sciences Corp.
  • Roche Ltd.
  • Illumina.
  • Merck KGaA
  • New England Biolabs
  • Pacific Biosciences
  • Sysmex Corporation
  • Zymo Research Corporation

For Additional Information on Key Players, Download a PDF Brochure:

Market Dynamics:

Key Growth Driving Factors

  • Rising number of cancer cases is favoring the market growth

The rising cancer cases continue to be the prominent factor driving the market growth. Increasing usage of DNA methylation in oncology research, reduction in the cost of treatment, and robust drug pipeline are expected to propel the DNA methylation market demand. Also, along with cancer, DNA methylation is used in the diagnosis of other diseases, including cardiovascular diseases, autoimmune diseases, imprinting disorders, and neurological disorders, which is accelerating the DNA methylation industry growth.  The noticeable growth of the biotechnology industry has led to an increase in the adoption of DNA methylation. The mechanism has been aiding researchers in findings responses to the effects of drought and environmental changes.

Recent Trends Influencing the Market

  • Increased number of R&D activities to create growth opportunities in the DNA methylation market
  • Various research and development activities carried out by government across the world is likely to create lucrative opportunities in the market. This is because DNA methylation promises conclusive results in core areas of chronic disease treatment.
  • In September 2022, a journal in Nature Communications stating published by the University of California researchers stated the possible use of cell-free DNA methylation as a biomarker for cancer detection in its early stages.

Directly Purchase a copy of the report with TOC @

Segmental Analysis

  • The sequencing segment is anticipated to grow at the fastest rate

Based on technology, the sequencing category is predicted to register the fastest growth during the forecast period. This growth can be attributed to the increasing advancement of technologies that offer quick, accurate, and affordable results that are positively influencing the segment growth of the DNA methylation market throughout the anticipated period. Genome sequencing, also known as complete genome sequencing, is majorly used by researchers during the study of disease morphology and its spread detection process, which supports segment growth.

  • Consumables held the highest revenue share in 2021

On the basis of product, the consumables segment accounted for the major DNA methylation market share in 202. Consumables products are mostly used in the diagnosis and DNA sequencing processes due to the accelerated turnaround times and huge throughput output. Rising requirement for consumables, including vials, microarray panels, tubes, dispensers, and pipette tips, is fueling the market growth.

  • The clinical research sector is likely to generate the considerable growth

By application, clinical research is expected to witness significant growth in the market owing to the growing number of clinical researchers across the globe for various diseases.  Also, growing demand for possible biomarkers and increasing R&D spending is expected to create significant opportunities. Further, the diagnostic segment is projected to show the largest market share throughout the study period.

Inquire more about this report before purchase @

(Inquire about a report quote OR available discount offers to the sales team before purchase.)

DNA Methylation Market: Global Report Scope

Report Attribute Details
Revenue forecast in 2030 USD 3,840.53 Million
Market size value in 2022 USD 1,301.39 Million
Expected CAGR Growth 14.5% from 2022 - 2030
Base Year 2021
Forecast Year 2022 - 2030
Top Market Players Abcam plc, Active Motif, Inc., Agilent Technologies Inc., BioRad Laboratories Inc., Diagenode Diagnostics S.A., EpiGentek Group Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs, Pacific Biosciences Inc., PerkinElmer Inc., QIAGEN N.V., Sysmex Corporation, Thermo-Fisher Scientific Inc., Zymo Research Corporation
Segments Covered By Technology, By Product, By Application, By End-use, By Region
Customization Options Customized purchase options are available to meet any research needs. Explore customized purchase options

Geographic Overview

  • The demand in North America is predicted to show a significant growth

Based on geography, DNA methylation market in North America is likely to grow at a significant rate due to the rising R&D and availability of manufacturing facilities. The market is booming due to the increasing need for protein expression systems. Rising consumer awareness about diseases such as cancer and other cardiovascular disorders, as well as the extensive R&D on DNA methylation in the region, are the key factors estimated to support the regional market growth.

Moreover, Asia Pacific is anticipated to register the fastest growth during the foreseen period owing to the rising government funding for various research activities along with the emergence of leading global players in the Asia Pacific is further expected to boost the market growth.

Browse the Detail Report “DNA Methylation Market Share, Size, Trends, Industry Analysis Report, By Technology (PCR, Microarray, Sequencing), By Application (Gene Therapy, Diagnostics), By Product, By End-use, By Region; Segment Forecast, 2022-30” with in-depth TOC:       

For Additional Information OR Media Enquiry, Please Mail At:

Recent Developments

  • In September 2020, AnchorDxentered announced the development of a liquid biopsy diagnostic model for early breast cancer diagnosis. This diagnostic model focuses on circulating DNA-based methylation patterns that are independent of cells.
  • In August 2022, Oncgnostics GmbH received recognition by the Chinese government to offer its GynTect test to medical professionals and patients. This is the first methylation test to be approved for the triage of cervical cancer cases in China.

Frequently Asked Questions

  • Who are the crucial companies operating the market?
  • What are the major industry norms influencing the development of the DNA methylation industry?
  • Which is the most propelling country in the industry?
  • Which application or product type will obtain progressive development possibilities during the forecast period?
  • What is the expected growth rate of the market during the foreseen period?
  • What are the key strategies adopted by companies in the impact market?
  • What are the main findings of Porter’s five forces analysis and the SWOT analysis of the major companies in the market?

Polaris Market Research has segmented the DNA methylation market report based on technology, product, application, end-use, and region:

By Technology Outlook

  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Sequencing
  • Other

By Product Outlook

  • Consumables
  • Kits & Reagents
  • Enzymes
  • Instrument and Software

By Application Outlook

  • Gene Therapy
  • Clinical Research
  • Diagnostics
  • Others

By End-use Outlook

  • Hospital & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research & Academia

By Region Outlook

  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Browse More Related Reports:

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.


Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727

Follow Us: LinkedIn twitter